Arkadios Wealth Advisors Bausch Health Companies Inc. Transaction History

Arkadios Wealth Advisors

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 03, 2022	SELL	$23.0 - $29.01 $2,806 - $3,539	-122 Closed	0 $0
Q3 2021 Oct 19, 2021	SELL	$25.04 - $30.06 $7,186 - $8,627	-287 Reduced 70.17%	122 $3,000
Q1 2021 Apr 26, 2021	SELL	$21.37 - $34.38 $2,414 - $3,884	-113 Reduced 21.65%	409 $12,000
Q4 2020 Feb 09, 2021	SELL	$15.31 - $21.12 $3,827 - $5,280	-250 Reduced 32.38%	522 $10,000
Q2 2020 Aug 10, 2020	BUY	$13.31 - $20.51 $8,651 - $13,331	650 Added 532.79%	772 $13.4 Million
Q4 2019 Feb 14, 2020	BUY	$18.89 - $31.89 $2,304 - $3,890	122 New	122 $3,000

253

240M

2.46M

8.42M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.39B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Arkadios Wealth Advisors, based on Form 13F filings with the SEC.

Stay updated on Arkadios Wealth Advisors with notifications on news.